CUSIP No. 00767E102
|
Page 1 of 3 Pages
|
Aegerion Pharmaceuticals, Inc.
|
(Name of Issuer)
|
Common Stock, $0.001 par value
|
(Title of Class of Securities)
|
00767E102
|
(CUSIP Number)
|
Mark DiPaolo
General Counsel
Sarissa Capital Management LP
660 Steamboat Road
Greenwich, CT 06830
203-302-2330
With a copy to:
Russell Leaf
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
212-728-8000
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications) |
March 21, 2016
|
(Date of Event which Requires Filing of this Statement)
|
CUSIP No. 00767E102
|
Page 2 of 3 Pages
|
CUSIP No. 00767E102
|
Page 3 of 3 Pages
|
SARISSA CAPITAL MANAGEMENT LP
|
||
By:
|
/s/ Mark DiPaolo
|
|
Name: Mark DiPaolo
|
||
Title: General Counsel
|
||
SARISSA CAPITAL DOMESTIC FUND LP
|
||
By: Sarissa Capital Fund GP LP, its general partner
|
||
By:
|
/s/ Mark DiPaolo
|
|
Name: Mark DiPaolo
|
||
Title: Authorized Person
|
||
SARISSA CAPITAL OFFSHORE MASTER FUND LP
|
||
By: Sarissa Capital Offshore Fund GP LLC, its general partner
|
||
By:
|
/s/ Mark DiPaolo
|
|
Name: Mark DiPaolo
|
||
Title: Authorized Person
|
||
/s/Alexander J. Denner
|
||
Alexander J. Denner
|
AEGERION PHARMACEUTICALS, INC.,
|
||
by
|
||
/s/ Gregory Perry | ||
Name: Gregory Perry
|
||
Title: CFO
|
SARISSA CAPITAL MANAGEMENT LP,
|
||
by
|
||
/s/ Mark DiPaolo
|
||
Name: Mark DiPaolo
|
||
Title: General Counsel
|
||
SARISSA CAPITAL DOMESTIC FUND LP,
|
||
by
|
||
/s/ Mark DiPaolo
|
||
Name: Mark DiPaolo
|
||
Title: Authorized Person
|
||
SARISSA CAPITAL OFFSHORE MASTER FUND LP,
|
||
by
|
||
/s/ Mark DiPaolo
|
||
Name: Mark DiPaolo
|
||
Title: Authorized Person
|
||
SARISSA CAPITAL FUND GP LP,
|
||
by
|
||
/s/ Mark DiPaolo
|
||
Name: Mark DiPaolo
|
||
Title: Authorized Person
|
||
SARISSA CAPITAL OFFSHORE FUND GP LLC,
|
||
by
|
||
/s/ Mark DiPaolo
|
||
Name: Mark DiPaolo
|
||
Title: Authorized Person
|